US Endoscopy Devices Market Size, Share, Growth, and Industry Forecast to 2031

0
28

Endoscopy Device reprocessing remains a critical protocol for reusable instruments that require thorough cleaning and high-level disinfection between patients. Automated endoscope reprocessors and strict sterilization standards ensure patient safety and extend equipment longevity.

The Endoscopy Devices Market size is expected to reach US$ 66.46 billion by 2031. The market is anticipated to register a CAGR of 6.0% during 2025–2031.

What is driving the market?

Rising prevalence of chronic disorders, global colorectal and gastric cancer screening programs, and strong clinical preference for minimally invasive interventions over open surgery are the principal growth drivers. Healthcare providers are increasingly adopting advanced endoscopic platforms to improve early lesion detection rates, streamline outpatient workflows, and manage growing procedural volumes.

The transition is moving beyond standard visualization toward smart, infection-safe ecosystems. Manufacturers are investing heavily in 4K/3D imaging towers, AI-assisted real-time polyp detection, and sterile single-use endoscopes designed to eliminate cross-contamination risks. High upfront capital costs for complete imaging towers, complex reprocessing and disinfection protocols for reusable scopes, and environmental waste concerns surrounding disposable units remain important constraints.

Which region leads?

North America leads the market, accounting for an estimated 39%–44% share in 2025. Its dominance is anchored by advanced healthcare infrastructure, high screening compliance, favorable reimbursement frameworks, and rapid migration of endoscopic procedures to outpatient settings.

Asia Pacific is the fastest-growing region, with a projected CAGR of 8.1%–9.2% through the forecast period. Growth is fueled by expanding healthcare expenditure, aging populations, and government-backed screening programs in China and India, alongside local manufacturing investments. Europe holds the second-largest regional position at roughly 25%–28% share, supported by regulatory modernization under EU MDR and national early-diagnosis initiatives.

Download Sample Report@ https://www.theinsightpartners.com/sample/TIPHE100000823

Which segment leads?

By product, Endoscopes (led by flexible endoscopes) represent the largest revenue segment, capturing approximately 41%–46% of market share in 2025. Their lead is driven by continuous replacement cycles and high procedural demand across diagnostic and therapeutic workflows. Single-use (disposable) endoscopes represent the fastest-growing usability sub-segment, projected to expand at an 11.75% CAGR as facilities tighten infection-control standards.

By application, Gastrointestinal (GI) endoscopy leads with an estimated 59.4% share in 2025, reflecting high global volumes of colonoscopies and upper-GI screenings. By end-use, Outpatient Facilities and Ambulatory Surgical Centers (ASCs) hold a dominant 53%–55% share due to cost efficiency and site-neutral payment reforms.

Which companies are prominent?

The competitive landscape features established global medical technology leaders including Olympus Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, PENTAX Medical (HOYA Corporation), Karl Storz SE & Co. KG, Stryker Corporation, Medtronic plc, and Ambu A/S.

These companies compete across flexible and rigid endoscopes, visualization processors, endoscopic operative instruments, and single-use platforms. Strategic differentiation increasingly depends on proprietary optical clarity, integrated AI diagnostic software, ergonomic scope design, and cost-effective single-use portfolios that lower hospital reprocessing overhead.

What is changing in 2026?

The market is shifting from standalone optical hardware toward AI-integrated, workflow-connected endoscopic suites. Clinical procurement in 2026 increasingly prioritizes real-time computer-aided detection (CADe) software, 4K fluorescence imaging, and strict adherence to updated FDA and EU medical device infection-control standards.

Manufacturers are also expanding localized production such as Fujifilm's endoscopy manufacturing facility launch in India in early 2026 to improve supply-chain resilience and price accessibility in emerging markets. Meanwhile, hospitals are adopting hybrid procurement models, pairing reusable scopes for routine high-volume cases with single-use scopes for high-risk duodenoscopy and bronchoscopy procedures.

What are the major investment opportunities?

The strongest opportunities lie in single-use endoscope commercialization, AI-as-a-Service diagnostic software, compact ASC tower bundles, and robotic-assisted flexible endoscopy. Developing lower-cost, high-clarity disposable scopes addresses hospital infection-control mandates while creating recurring consumable revenue streams.

Additional opportunities include cloud-connected procedure analytics, automated endoscope reprocessing systems, and mid-tier endoscopic platforms tailored for emerging markets. Asia Pacific offers compelling expansion potential as public health programs in India and China bring hundreds of millions of additional patients into routine cancer-screening eligibility.

Future Outlook

Looking ahead toward 2031, the endoscopy device landscape will be defined by autonomous navigation, robotic-assisted flexible platforms, and precision therapeutic integration. Next-generation robotic systems are expected to reduce procedure times, minimize operator fatigue, and extend endoscopic reach into complex anatomical pathways. Simultaneously, equipment vendors will increasingly transition from one-time capital sales toward subscription and per-procedure pricing models, while balancing single-use convenience with medical-grade plastics recycling and sustainable scope life-cycle management.

Related Reports:

Anti-Radiation Drugs Market Trends, Demand & Growth by 2034

Orthodontic Equipment Market Growth, Size & Forecast by 2034

Bispecific Antibodies CDMO Market 2026-2034 | Growth & Forecast

About The Insight Partners

The Insight Partners is a leading market research and consulting firm delivering actionable insights through in-depth industry analysis and strategic intelligence. The firm supports clients across various industries in making informed decisions by providing comprehensive market forecasts, competitive assessments, and growth opportunities.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Also Available in : Korean| German| Japanese| French| Chinese| Italian| Spanish

Поиск
Категории
Больше
Другое
Software Testing Course in Chennai
Beginners in software testing can benefit from understanding test automation best practices to...
От Nirmala Devi5 2026-05-13 11:50:26 0 3Кб
Другое
Cell-Free Protein Expression Systems Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033
Cell-Free Protein Expression Systems Market  According to the latest report published by...
От Rohit Sharma 2026-08-11 10:33:06 0 2Кб
Health
From Alerts to Insights: How the Clinical Decision Support Systems Market Is Evolving
Clinical decision support systems (CDSS) give clinicians real-time alerts, evidence-based...
От Toman Clark 2026-11-10 06:51:43 0 218
Другое
Why to choose Digital Marketing as a career?
Why choose Digital Marketing as a career? A digital marketing career is one of the premium...
От Willy Lilly 2026-05-06 15:48:04 0 3Кб
Art
Kuwait Crowdfunding Platform Market Size to Reach USD 14,549.35 Thousand by 2034, Growing at 8.8% CAGR
The Kuwait Crowdfunding Platform Market is witnessing significant transformation, shaped by...
От Prajwal Agale 2026-08-23 12:20:30 0 1Кб
SocioMint https://sociomint.com